Cancer-cell-derived exosomes (sEVs) that express the inhibitory immune checkpoint ligand PD-L1 have been reported to suppress CD8+ T cells7,9, and suppression of exosomal PD-L1 is reported to induce antitumour immunity9. The gene discussed is CD8A; the disease is cancer.